Syd Labs, Inc.于 2010 年初创立于美国波士顿，采用重组技术生产有活性的蛋白质，包括重组抗体、重组抗原、重组酶、重组细胞因子以及其它重组蛋白，努力提高蛋白产量和活性、降低成本和价格、尽量避免使用动物作为生产工具。
悉得实验室(Syd Labs, 简称"悉得”)强烈呼吁珍爱生命、减少使用动物生产抗体!
悉得（Syd Labs）重点推荐
|
Anti-mouse antibodies (in vivo) |
体内实验级重组抗小鼠靶点抗体 |
|
Isotype control antibodies |
同型对照抗体 |
|
Research grade biosimilars |
科研级生物类似药 |
|
Anti-human antibodies (in vivo) |
体内实验级重组抗人靶点抗体 |
体内实验级重组抗小鼠靶点抗体
|
货号 |
产品名称 |
规格 |
|
PA007162.r2a |
Anti-mouse PD-1 (clone RMP1-14.1), rIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007163.r2a |
Anti-mouse PD-1 (clone 29F.1A12.1), rIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007164.r2b |
Anti-mouse PD-L1 (clone 10F.9G2.1), rIgG2b |
1 mg; 5 mg; 25 mg |
|
PA007162.m2aLA |
Anti-mouse PD-1 (clone RMP1-14.1), mIgG2a LALAPG |
1 mg; 5 mg; 25 mg |
|
PA007162.m2cLA |
Anti-mouse PD-1 (clone RMP1-14.1), mIgG2c LALAPG |
1 mg; 5 mg; 25 mg |
|
PA007163.m2aLA |
Anti-mouse PD-1 (clone 29F.1A12.1), mIgG2a LALAPG |
1 mg; 5 mg; 25 mg |
|
PA007163.m2cLA |
Anti-mouse PD-1 (clone 29F.1A12.1), mIgG2c LALAPG |
1 mg; 5 mg; 25 mg |
|
PA007164.m2aLA |
Anti-mouse PD-L1 (clone 10F.9G2.1), mIgG2a LALAPG |
1 mg; 5 mg; 25 mg |
|
PA007164.m2cLA |
Anti-mouse PD-L1 (clone 10F.9G2.1), mIgG2c LALAPG |
1 mg; 5 mg; 25 mg |
|
PA007199.r2b |
Anti-mouse CD3 (clone 17A2), rIgG2b |
1 mg; 5 mg; 25 mg |
|
PA007198 |
Anti-mouse CD3e (clone 145-2C11), mIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007201 |
Anti-mouse CD3e (clone 500A2), mIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007200.r2b |
Anti-mouse CD4 (clone GK1.5), rIgG2b |
1 mg; 5 mg; 25 mg |
|
PA007166.r2b |
Anti-Mouse CD8a (clone YTS 169.4), rIgG2b |
1 mg; 5 mg; 25 mg |
|
PA007167.r2b |
Anti-Mouse CD8a (clone 2.43), rIgG2b |
1 mg; 5 mg; 25 mg |
|
PA007363.r2a |
Anti-mouse CD19 (clone 1D3), rIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007156.r1 |
Anti-mouse CD25 (clone PC61.5.3), rIgG1 Lambda |
1 mg; 5 mg; 25 mg |
|
PA007274.r2a |
Anti-mouse CD40 (clone FGK4.5), rIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007276.r2a |
Anti-mouse CD137 (TNFRSF9/4-1BB) (clone 3H3), rIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007275.r1 |
Anti-mouse CD137 (TNFRSF9/4-1BB) (clone LOB12 .3), rIgG1 |
1 mg; 5 mg; 25 mg |
|
PA007168.r1 |
Anti-mouse OX40 (clone OX86), rIgG1 |
1 mg; 5 mg; 25 mg |
|
PA007280.m2a |
Anti-mouse TIG IT (clone 1F4), mIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007279.m2a |
Anti-mouse TIG IT (clone 10A7), mIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007169.r2b |
Anti-mouse GITR (clone DTA-1), rIgG2a Lambda |
1 mg; 5 mg; 25 mg |
同型对照抗体
|
货号 |
产品名称 |
规格 |
|
PA007125 |
Human IgG1 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007128 |
Human IgG4-S228P Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007134 |
Human IgG1-LALAPG Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007133 |
Human IgG1-N297A Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007132 |
Human IgG1-D265A Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007127 |
Human IgG2 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007187 |
Chimeric Human IgG1 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007165.h 1 |
VHH-hIgG1 Fc Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007126 |
Mouse IgG1 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007135 |
Mouse IgG1-D265A Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007129 |
Mouse IgG2a Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007138 |
Mouse IgG2a-LALAPG Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007130 |
Mouse IgG2bIsotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA005171 |
Mouse IgG2c Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007141 |
Mouse IgG2c-LALAPG Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007161 |
Mouse IgG3 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007142 |
Rat IgG1 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007143 |
Rat IgG2a Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007144 |
Rat IgG2bIsotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007145 |
Rat IgG2c Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007153.m1 |
Anti-HEL (D1.3) Mouse IgG1 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007154.m1 |
Anti-HEL (HyHEL-10) Mouse IgG1 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007155.m1 |
MOPC-21 Mouse IgG1 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007158.m1 |
Anti-DNP Mouse IgG1 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007151.m1 |
B1-8 Mouse IgG1 Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
PA007165.m2a |
VHH-mIgG2a Fc Isotype Control Antibody |
1 mg; 5 mg; 25 mg |
|
BP4091 |
Human IgG1 Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4092 |
Human IgG2 Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4125 |
Human IgG3 Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4093 |
Human IgG4 Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4111 |
Mouse IgG1 Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4120 |
Mouse IgG2a Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4121 |
Mouse IgG2b Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4123 |
Mouse IgG2c Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4124 |
Mouse IgG3 Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4126 |
Rat IgG2a Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4127 |
Rat IgG2b Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4122 |
Rabbit IgG Fc Protein |
1 mg; 5 mg; 25 mg |
|
BP4119 |
Llama IgG2b Fc Protein |
1 mg; 5 mg; 25 mg |
科研级生物类似药
|
货号 |
产品名称 |
规格 |
|
C007P |
A batacept Biosimilar |
1 mg; 5 mg; 20 mg |
|
C003P |
Adalimumab Biosimilar, Human TNF alpha |
1 mg; 5 mg; 20 mg |
|
C013P |
Aflibercept Biosimilar |
1 mg; 5 mg; 20 mg |
|
C040P |
Alemtuzumab Biosimilar, Human CD52 |
1 mg; 5 mg; 20 mg |
|
C024P |
Atezolizumab Biosimilar, Human PD-L1 |
1 mg; 5 mg; 20 mg |
|
C008P |
Belatacept Biosimilar |
1 mg; 5 mg; 20 mg |
|
C001P |
Bevacizumab Biosimilar, Human VEGF |
1 mg; 5 mg; 20 mg |
|
C041P |
Briakinumab Biosimilar, Human IL-12 / IL-23 |
1 mg; 5 mg; 20 mg |
|
C002P |
Cetuximab Biosimilar, Human EGFR |
1 mg; 5 mg; 20 mg |
|
C042P |
Clenoliximab Biosimilar, Human CD4 |
1 mg; 5 mg; 20 mg |
|
C043P |
Daclizumab Biosimilar, Human CD25 |
1 mg; 5 mg; 20 mg |
|
C030P |
Daratumumab Biosimilar, Human CD38 |
1 mg; 5 mg; 20 mg |
|
C004P |
Denosumab Biosimilar, Human RANKL |
1 mg; 5 mg; 20 mg |
|
C044P |
Drozitumab Biosimilar, Human TRAIL |
1 mg; 5 mg; 20 mg |
|
C022P |
Eculizumab Biosimilar, Human C5 |
1 mg; 5 mg; 20 mg |
|
C045P |
Efalizumab Biosimilar, Human CD11a |
1 mg; 5 mg; 20 mg |
|
C046P |
Epratuzumab Biosimilar, Human CD22 |
1 mg; 5 mg; 20 mg |
|
C058P |
Ibalizumab Biosimilar, Human CD4 |
1 mg; 5 mg; 20 mg |
|
C011P |
Infliximab Biosimilar, Human TNF alpha |
1 mg; 5 mg; 20 mg |
|
C033P |
Minretumomab Biosimilar, Human TAG-72 |
1 mg; 5 mg; 20 mg |
|
C055P |
Natalizumab Biosimilar, Human Integrin alpha 4 |
1 mg; 5 mg; 20 mg |
|
C026P |
Nivolumab Biosimilar, Human PD-1 |
1 mg; 5 mg; 20 mg |
|
C020P |
Omalizumab Biosimilar, Human IgE |
1 mg; 5 mg; 20 mg |
|
C021P |
Palivizumab Biosimilar, RSV |
1 mg; 5 mg; 20 mg |
|
C012P |
Panitumumab Biosimilar, Human EGFR/ErbB-1/HER1 |
1 mg; 5 mg; 20 mg |
|
C027P |
Pembrolizumab Biosimilar, Human PD-1 |
1 mg; 5 mg; 20 mg |
|
C006P |
Pertuzumab Biosimilar, Human HER2 |
1 mg; 5 mg; 20 mg |
|
C052P |
Polatuzumab Biosimilar, Human CD79B |
1 mg; 5 mg; 20 mg |
|
C005P |
Ranibizumab Biosimilar, Human VEGF Fragment (Fab) |
1 mg; 5 mg; 20 mg |
|
C062P |
Relatlimab Biosimilar, Human LAG-3 |
1 mg; 5 mg; 20 mg |
|
C010P |
Rituximab Biosimilar, Human CD20 |
1 mg; 5 mg; 20 mg |
|
C071P |
Sacituzumab Biosimilar, Human Trop-2 |
1 mg; 5 mg; 20 mg |
|
C034P |
Secukinumab Biosimilar, Human IL17A |
1 mg; 5 mg; 20 mg |
|
C110P |
Tanezumab Biosimilar, Human NGF |
1 mg; 5 mg; 20 mg |
|
C056P |
Teplizumab Biosimilar, Human CD3e |
1 mg; 5 mg; 20 mg |
|
C032P |
Tocilizumab Biosimilar, Human IL-6R |
1 mg; 5 mg; 20 mg |
|
C009P |
Trastuzumab Biosimilar, Human HER2 |
1 mg; 5 mg; 20 mg |
|
C037P |
Tremelimumab Biosimilar, Human CTLA-4 |
1 mg; 5 mg; 20 mg |
|
C038P |
Ustekinumab Biosimilar, Human IL-12 / IL-23 |
1 mg; 5 mg; 20 mg |
|
C070P |
Zolbetuximab Biosimilar, Human Claudin 18.2 |
1 mg; 5 mg; 20 mg |
体内实验级重组抗人靶点抗体
|
货号 |
产品名称 |
规格 |
|
PA007157.m1 |
Anti-Human HER2/ErbB-2/c-neu (clone muMab 4D5), mIgG1 |
1 mg; 5 mg; 25 mg |
|
PA007196 |
Anti-human CD3 (clone SP34-2), mIgG1 |
1 mg; 5 mg; 25 mg |
|
PA007197 |
Anti-human CD3e (clone UCHT1), mIgG1 |
1 mg; 5 mg; 25 mg |
|
PA007202.m2a |
Anti-human CD3e (clone OKT3), mIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007277.m1 |
Anti-human CD16 (clone 3G8), mIgG1 |
1 mg; 5 mg; 25 mg |
|
PA007271.m2a |
Anti-human CD19 (clone FMC63), mIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007270.m1 |
Anti-human CD19 (clone SJ25C1), mIgG1 |
1 mg; 5 mg; 25 mg |
|
PA007272.m2a |
Anti-human CD19 (clone B43), mIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007273.m2a |
Anti-human Siglec-2/CD22 (clone NCI m971), mIgG2a |
1 mg; 5 mg; 25 mg |
|
PA007278.m1 |
Anti-human CD56 (clone N901), mIgG1 |
1 mg; 5 mg; 25 mg |
标签抗体
|
货号 |
产品名称 |
规格 |
|
PA000274.m1 |
Anti-DYKDDDDK-Tag (clone M2.1), mIgG1 |
50 ug; 100 ug; 200 ug; 1 mg; 5 mg |
|
PA000002.m1 |
Anti-Myc-Tag (clone 9E10), mIgG1 |
50 ug; 100 ug; 200 ug; 1 mg; 5 mg |
|
PA007281.m2b |
Anti-HA-Tag (clone 12CA5), mIgG2b |
50 ug; 100 ug; 200 ug; 1 mg; 5 mg |
|
PA007282.m2b |
Anti-His-Tag (clone 3D5), mIgG2b |
50 ug; 100 ug; 200 ug; 1 mg; 5 mg |
D-荧光素钾盐
|
货号 |
产品名称 |
规格 |
|
MB000102-R70170 |
D-Luciferin Potassium Salt |
1 g; 10 g |
悉得（Syd Labs）技术优势
1 、 采用抗体药物生产中常用的化学成分确定的培养基和 CHO 细胞，没有来自 小鼠腹水和细胞培养基里 FBS 的抗体污染, 没有杂交瘤批次之间的不稳定性；
2 、 可以进行自由工程改造，包括切换 isotype 、Fc 突变、提升亲和力和产量；
3 、 在同等内毒素标准下价格比国外同行低至 50% ，内毒素可低至 0.05 EU/mg （FDA 对临床产品的质量要求），属于当前科研抗体内毒素水平的天花板。
